The authors have no conflict of interest.
Estrogen Receptor β Polymorphisms Are Associated With Bone Mass in Women and Men: The Framingham Study†
Article first published online: 22 DEC 2003
Copyright © 2004 ASBMR
Journal of Bone and Mineral Research
Volume 19, Issue 5, pages 773–781, May 2004
How to Cite
Shearman, A. M., Karasik, D., Gruenthal, K. M., Demissie, S., Cupples, L. A., Housman, D. E. and Kiel, D. P. (2004), Estrogen Receptor β Polymorphisms Are Associated With Bone Mass in Women and Men: The Framingham Study. J Bone Miner Res, 19: 773–781. doi: 10.1359/jbmr.0301258
- Issue published online: 2 DEC 2009
- Article first published online: 22 DEC 2003
- Manuscript Accepted: 19 DEC 2003
- Manuscript Revised: 17 DEC 2003
- Manuscript Received: 13 JUN 2003
- estrogen receptor β;
ESR2 is expressed in bone cells, yet few studies have tested its variation for association with BMD, an important determinant of osteoporotic fractures. This was investigated in 723 men and 795 women from the Framingham study. Results show association of variation in this gene with BMD in both women and men.
Introduction: Osteoporotic fracture risk is highly dependent on bone density, a quantitative multifactorial trait with a substantial genetic component. In contrast to the growing body of evidence that estrogen receptor α (ESR1) plays a role in bone metabolism, few studies have examined the estrogen receptor β (ESR2) gene for association with BMD. An ESR2 CA repeat polymorphism, D14S1026, was associated with BMD in two small studies, each with <200 women.
Materials and Methods: The objective of this investigation was to assess whether D14S1026 or four other intronic polymorphisms were associated with BMD in 723 men and 795 women (mean age, 60 years) from the offspring cohort of the population-based Framingham Study. BMD was measured at the femur (neck, trochanter, and Ward's area) and the lumbar spine (L2-L4).
Results: In both women and men, there was significant association of D14S1026 genotype with measures of femoral but not spinal BMD. In addition, genotypes of two common single nucleotide polymorphisms, rs1256031 and rs1256059, in strong linkage disequilibrium with one another but not with D14S1026, were associated with measures of femoral BMD in men. The rs1256031 genotypes had up to a 4.0% difference in mean femoral BMD. An inferred rs1256031-D14S1026-rs1256059 haplotype C-23CA-T was significantly associated with reduced femoral BMD in women (p = 0.03, 0.003, and 0.01 for neck, trochanter, and Ward's area, respectively). Haplotype-based BMD differences ranged from 3.0% to 4.3%.
Conclusions: We have observed significant association of common ESR2 variants with measures of femoral BMD in both men and women.